|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1162843209 |
| 003 |
OCoLC |
| 005 |
20231120010500.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
200705s2020 enk o 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d UIU
|d OPELS
|d OCLCF
|d NLW
|d SFB
|d N$T
|d OCLCO
|d SFB
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9780128224960
|q (electronic bk.)
|
| 020 |
|
|
|a 0128224967
|q (electronic bk.)
|
| 020 |
|
|
|z 0128224819
|
| 020 |
|
|
|z 9780128224816
|
| 035 |
|
|
|a (OCoLC)1162843209
|
| 050 |
|
4 |
|a QP535.O1
|
| 060 |
|
4 |
|a QV 312
|
| 082 |
0 |
4 |
|a 572/.53
|2 23
|
| 100 |
1 |
|
|a Madkour, Loutfy H.
|q (Loutfy Hamid),
|e author.
|
| 245 |
1 |
0 |
|a Reactive oxygen species (ROS), nanoparticles, and endoplasmic reticulum (ER) stress-induced cell death mechanisms /
|c Loutfy H. Madkour.
|
| 264 |
|
1 |
|a London :
|b Academic Press,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 505 |
0 |
|
|a FDA breakthrough (BT)- -- drug therapy designations for clinical evidence Appendix: List of abbreviations
|
| 650 |
|
0 |
|a Active oxygen.
|
| 650 |
|
2 |
|a Reactive Oxygen Species
|0 (DNLM)D017382
|
| 650 |
|
6 |
|a Oxyg�ene actif.
|0 (CaQQLa)201-0023010
|
| 650 |
|
7 |
|a Active oxygen
|2 fast
|0 (OCoLC)fst00796282
|
| 776 |
0 |
8 |
|i Print version:
|z 0128224819
|z 9780128224816
|w (OCoLC)1135669797
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128224816
|z Texto completo
|
